Skip to main content
. 2021 Jul 4;2021:5707242. doi: 10.1155/2021/5707242

Figure 5.

Figure 5

Curculigoside treatment inhibited Ti-induced activation of osteoclast activity in BMSCs. (a) After being intervened with Ti and treated with curculigoside at different concentrations (25, 50, and 100 μg/ml) for 48 h, BMSC viability was detected by the CCK-8 assay (n = 6). (b) The levels of TNF-α, IL-1β, and IL-6 in BMSCs were detected using ELISA kits. (c) Cellular immunofluorescence of F-actin in BMSCs (n = 3); results are represented as the mean ± SD. P < 0.05, compared to the Con group; ▲▲P < 0.01, compared to the Con group; P < 0.05, compared to the Ti group; ∗∗P < 0.01, compared to the Ti group. BMSCs: bone marrow stromal cells; Ti: titanium particles; Con: control.